
FDA Watch: OraSure’s Collection Device for Cobas STI Testing Receives Approval
At-home sample collections can be mailed to a clinical laboratory

At-home sample collections can be mailed to a clinical laboratory

Its FungiFlex assay can make determining the cause of fungal infections vastly more accurate

The proposal seeks to move any future LDT authority away from the FDA

Natera’s assay focuses on the need for adjuvant therapy, while Valar’s test stratifies risk of recurrence

FDA-CMS collaboration aims to accelerate Medicare coverage determinations of certain medical devices